Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bespak in talks with potential acquirer:

This article was originally published in Clinica

Executive Summary

UK drug delivery device manufacturer Bespak today revealed it is in "very preliminary" discussions with an unnamed party over a potential takeover bid for the company. The news gave a boost to the UK firm's shares, which have taken a tumble over recent months following disappointing sales of its Exubera insulin inhaler (see Clinica No 1265, p 13). Nomura Code analyst Charles Weston suggested that Bespak's potential suitors could include other medical device plastics manufacturer, who could generate significant cost synergies, or leveraged buy-out firms, who could use the company's strong free cash flow generation to "heavily gear the balance sheet".

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048602

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel